nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvoxamine—endogenous depression—Citalopram—alcohol dependence	0.182	0.536	CpDpCtD
Fluvoxamine—panic disorder—Citalopram—alcohol dependence	0.157	0.464	CpDpCtD
Fluvoxamine—SLC6A3—alcohol dependence	0.107	0.406	CbGaD
Fluvoxamine—SLC6A4—alcohol dependence	0.0803	0.304	CbGaD
Fluvoxamine—CYP2E1—alcohol dependence	0.0769	0.291	CbGaD
Fluvoxamine—SLC6A3—Citalopram—alcohol dependence	0.0409	0.168	CbGbCtD
Fluvoxamine—SLC6A4—Citalopram—alcohol dependence	0.0358	0.147	CbGbCtD
Fluvoxamine—CYP2E1—Disulfiram—alcohol dependence	0.0265	0.108	CbGbCtD
Fluvoxamine—CYP3A5—Disulfiram—alcohol dependence	0.0206	0.0841	CbGbCtD
Fluvoxamine—CYP2E1—Citalopram—alcohol dependence	0.0188	0.0772	CbGbCtD
Fluvoxamine—CYP2B6—Citalopram—alcohol dependence	0.0186	0.0761	CbGbCtD
Fluvoxamine—ABCB1—Naltrexone—alcohol dependence	0.0144	0.0589	CbGbCtD
Fluvoxamine—CYP2C9—Disulfiram—alcohol dependence	0.0138	0.0564	CbGbCtD
Fluvoxamine—CYP2C19—Citalopram—alcohol dependence	0.0118	0.0484	CbGbCtD
Fluvoxamine—CYP1A2—Citalopram—alcohol dependence	0.0109	0.0446	CbGbCtD
Fluvoxamine—ABCB1—Citalopram—alcohol dependence	0.00953	0.039	CbGbCtD
Fluvoxamine—CYP2D6—Citalopram—alcohol dependence	0.00898	0.0368	CbGbCtD
Fluvoxamine—CYP3A4—Disulfiram—alcohol dependence	0.00801	0.0328	CbGbCtD
Fluvoxamine—CYP3A4—Citalopram—alcohol dependence	0.00571	0.0234	CbGbCtD
Fluvoxamine—SLC6A3—nerve—alcohol dependence	0.000687	0.0529	CbGeAlD
Fluvoxamine—SLC6A3—brainstem—alcohol dependence	0.000295	0.0227	CbGeAlD
Fluvoxamine—SLC6A3—forebrain—alcohol dependence	0.000285	0.0219	CbGeAlD
Fluvoxamine—CYP3A7—endocrine gland—alcohol dependence	0.000281	0.0216	CbGeAlD
Fluvoxamine—SLC6A4—brainstem—alcohol dependence	0.00027	0.0208	CbGeAlD
Fluvoxamine—SLC6A4—forebrain—alcohol dependence	0.000261	0.0201	CbGeAlD
Fluvoxamine—CYP3A7—liver—alcohol dependence	0.000253	0.0195	CbGeAlD
Fluvoxamine—SIGMAR1—adrenal cortex—alcohol dependence	0.00024	0.0185	CbGeAlD
Fluvoxamine—CYP3A7-CYP3A51P—liver—alcohol dependence	0.000215	0.0166	CbGeAlD
Fluvoxamine—SIGMAR1—pancreas—alcohol dependence	0.000213	0.0164	CbGeAlD
Fluvoxamine—SLC6A3—midbrain—alcohol dependence	0.000188	0.0145	CbGeAlD
Fluvoxamine—SLC6A4—digestive system—alcohol dependence	0.000183	0.0141	CbGeAlD
Fluvoxamine—SLC6A4—blood—alcohol dependence	0.000174	0.0134	CbGeAlD
Fluvoxamine—SIGMAR1—blood—alcohol dependence	0.000173	0.0133	CbGeAlD
Fluvoxamine—SLC6A4—midbrain—alcohol dependence	0.000172	0.0133	CbGeAlD
Fluvoxamine—SIGMAR1—midbrain—alcohol dependence	0.000171	0.0132	CbGeAlD
Fluvoxamine—SLC6A3—testis—alcohol dependence	0.000157	0.0121	CbGeAlD
Fluvoxamine—CYP2B6—adrenal cortex—alcohol dependence	0.000157	0.0121	CbGeAlD
Fluvoxamine—SLC6A3—nervous system—alcohol dependence	0.000155	0.0119	CbGeAlD
Fluvoxamine—CYP2C19—digestive system—alcohol dependence	0.000152	0.0117	CbGeAlD
Fluvoxamine—SLC6A4—endocrine gland—alcohol dependence	0.000151	0.0116	CbGeAlD
Fluvoxamine—SLC6A3—central nervous system—alcohol dependence	0.000149	0.0115	CbGeAlD
Fluvoxamine—SLC6A3—cerebellum—alcohol dependence	0.000145	0.0112	CbGeAlD
Fluvoxamine—CYP2C19—blood—alcohol dependence	0.000145	0.0111	CbGeAlD
Fluvoxamine—SIGMAR1—testis—alcohol dependence	0.000143	0.011	CbGeAlD
Fluvoxamine—CYP2B6—cardiovascular system—alcohol dependence	0.000143	0.011	CbGeAlD
Fluvoxamine—CYP2C9—cardiovascular system—alcohol dependence	0.000142	0.0109	CbGeAlD
Fluvoxamine—SLC6A4—nervous system—alcohol dependence	0.000142	0.0109	CbGeAlD
Fluvoxamine—CYP3A5—pancreas—alcohol dependence	0.00014	0.0108	CbGeAlD
Fluvoxamine—SLC6A4—central nervous system—alcohol dependence	0.000136	0.0105	CbGeAlD
Fluvoxamine—SIGMAR1—liver—alcohol dependence	0.000135	0.0104	CbGeAlD
Fluvoxamine—CYP2E1—cardiovascular system—alcohol dependence	0.000134	0.0103	CbGeAlD
Fluvoxamine—SIGMAR1—cerebellum—alcohol dependence	0.000132	0.0102	CbGeAlD
Fluvoxamine—CYP2D6—brainstem—alcohol dependence	0.00013	0.01	CbGeAlD
Fluvoxamine—CYP2B6—gonad—alcohol dependence	0.00013	0.01	CbGeAlD
Fluvoxamine—CYP2D6—forebrain—alcohol dependence	0.000126	0.00968	CbGeAlD
Fluvoxamine—CYP2C19—endocrine gland—alcohol dependence	0.000125	0.00965	CbGeAlD
Fluvoxamine—CYP1A2—digestive system—alcohol dependence	0.000124	0.00954	CbGeAlD
Fluvoxamine—CYP1A1—digestive system—alcohol dependence	0.000122	0.00941	CbGeAlD
Fluvoxamine—CYP3A5—digestive system—alcohol dependence	0.00012	0.0092	CbGeAlD
Fluvoxamine—CYP2B6—digestive system—alcohol dependence	0.000119	0.00915	CbGeAlD
Fluvoxamine—SLC6A3—brain—alcohol dependence	0.000118	0.00909	CbGeAlD
Fluvoxamine—CYP1A2—blood—alcohol dependence	0.000118	0.00909	CbGeAlD
Fluvoxamine—CYP2C9—digestive system—alcohol dependence	0.000118	0.00906	CbGeAlD
Fluvoxamine—CYP1A1—blood—alcohol dependence	0.000116	0.00897	CbGeAlD
Fluvoxamine—CYP3A5—blood—alcohol dependence	0.000114	0.00877	CbGeAlD
Fluvoxamine—CYP2B6—blood—alcohol dependence	0.000113	0.00871	CbGeAlD
Fluvoxamine—CYP2C19—liver—alcohol dependence	0.000113	0.0087	CbGeAlD
Fluvoxamine—CYP2C9—blood—alcohol dependence	0.000112	0.00863	CbGeAlD
Fluvoxamine—CYP2E1—digestive system—alcohol dependence	0.000111	0.00858	CbGeAlD
Fluvoxamine—SLC6A4—brain—alcohol dependence	0.000108	0.00833	CbGeAlD
Fluvoxamine—SIGMAR1—brain—alcohol dependence	0.000108	0.00828	CbGeAlD
Fluvoxamine—CYP2E1—blood—alcohol dependence	0.000106	0.00818	CbGeAlD
Fluvoxamine—CYP1A2—endocrine gland—alcohol dependence	0.000102	0.00788	CbGeAlD
Fluvoxamine—CYP1A1—endocrine gland—alcohol dependence	0.000101	0.00778	CbGeAlD
Fluvoxamine—CYP3A5—endocrine gland—alcohol dependence	9.88e-05	0.0076	CbGeAlD
Fluvoxamine—CYP2B6—endocrine gland—alcohol dependence	9.82e-05	0.00756	CbGeAlD
Fluvoxamine—CYP2C9—endocrine gland—alcohol dependence	9.72e-05	0.00748	CbGeAlD
Fluvoxamine—CYP1A1—nervous system—alcohol dependence	9.45e-05	0.00728	CbGeAlD
Fluvoxamine—CYP2B6—testis—alcohol dependence	9.36e-05	0.00721	CbGeAlD
Fluvoxamine—CYP1A2—liver—alcohol dependence	9.23e-05	0.00711	CbGeAlD
Fluvoxamine—CYP2E1—endocrine gland—alcohol dependence	9.21e-05	0.00709	CbGeAlD
Fluvoxamine—CYP2B6—nervous system—alcohol dependence	9.19e-05	0.00707	CbGeAlD
Fluvoxamine—CYP1A1—liver—alcohol dependence	9.11e-05	0.00701	CbGeAlD
Fluvoxamine—CYP1A1—central nervous system—alcohol dependence	9.1e-05	0.00701	CbGeAlD
Fluvoxamine—ABCB1—forebrain—alcohol dependence	9.05e-05	0.00696	CbGeAlD
Fluvoxamine—CYP3A4—digestive system—alcohol dependence	8.97e-05	0.00691	CbGeAlD
Fluvoxamine—CYP3A5—liver—alcohol dependence	8.91e-05	0.00686	CbGeAlD
Fluvoxamine—CYP2B6—liver—alcohol dependence	8.85e-05	0.00681	CbGeAlD
Fluvoxamine—CYP2B6—central nervous system—alcohol dependence	8.85e-05	0.00681	CbGeAlD
Fluvoxamine—CYP2D6—digestive system—alcohol dependence	8.83e-05	0.0068	CbGeAlD
Fluvoxamine—CYP2E1—testis—alcohol dependence	8.79e-05	0.00676	CbGeAlD
Fluvoxamine—CYP2C9—liver—alcohol dependence	8.76e-05	0.00675	CbGeAlD
Fluvoxamine—CYP2E1—nervous system—alcohol dependence	8.62e-05	0.00664	CbGeAlD
Fluvoxamine—CYP3A4—blood—alcohol dependence	8.55e-05	0.00658	CbGeAlD
Fluvoxamine—CYP2D6—blood—alcohol dependence	8.41e-05	0.00647	CbGeAlD
Fluvoxamine—ABCB1—adrenal cortex—alcohol dependence	8.38e-05	0.00645	CbGeAlD
Fluvoxamine—CYP2E1—liver—alcohol dependence	8.31e-05	0.00639	CbGeAlD
Fluvoxamine—CYP2E1—central nervous system—alcohol dependence	8.3e-05	0.00639	CbGeAlD
Fluvoxamine—CYP2E1—cerebellum—alcohol dependence	8.11e-05	0.00625	CbGeAlD
Fluvoxamine—ABCB1—cardiovascular system—alcohol dependence	7.65e-05	0.00589	CbGeAlD
Fluvoxamine—ABCB1—pancreas—alcohol dependence	7.44e-05	0.00572	CbGeAlD
Fluvoxamine—CYP3A4—endocrine gland—alcohol dependence	7.41e-05	0.00571	CbGeAlD
Fluvoxamine—CYP2D6—endocrine gland—alcohol dependence	7.29e-05	0.00561	CbGeAlD
Fluvoxamine—Muscle spasms—Acamprosate—alcohol dependence	7.28e-05	0.000746	CcSEcCtD
Fluvoxamine—Face oedema—Citalopram—alcohol dependence	7.28e-05	0.000746	CcSEcCtD
Fluvoxamine—Alopecia—Naltrexone—alcohol dependence	7.27e-05	0.000745	CcSEcCtD
Fluvoxamine—CYP1A1—brain—alcohol dependence	7.23e-05	0.00556	CbGeAlD
Fluvoxamine—Mental disorder—Naltrexone—alcohol dependence	7.21e-05	0.000739	CcSEcCtD
Fluvoxamine—Irritability—Citalopram—alcohol dependence	7.19e-05	0.000737	CcSEcCtD
Fluvoxamine—Cardiac arrest—Citalopram—alcohol dependence	7.17e-05	0.000735	CcSEcCtD
Fluvoxamine—Urinary retention—Citalopram—alcohol dependence	7.17e-05	0.000735	CcSEcCtD
Fluvoxamine—Malnutrition—Naltrexone—alcohol dependence	7.16e-05	0.000734	CcSEcCtD
Fluvoxamine—Mood swings—Citalopram—alcohol dependence	7.14e-05	0.000732	CcSEcCtD
Fluvoxamine—Tremor—Acamprosate—alcohol dependence	7.09e-05	0.000727	CcSEcCtD
Fluvoxamine—Ataxia—Citalopram—alcohol dependence	7.09e-05	0.000726	CcSEcCtD
Fluvoxamine—Flatulence—Naltrexone—alcohol dependence	7.06e-05	0.000723	CcSEcCtD
Fluvoxamine—Tension—Naltrexone—alcohol dependence	7.03e-05	0.00072	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Acamprosate—alcohol dependence	7.03e-05	0.00072	CcSEcCtD
Fluvoxamine—CYP2B6—brain—alcohol dependence	7.02e-05	0.00541	CbGeAlD
Fluvoxamine—Dysgeusia—Naltrexone—alcohol dependence	7.02e-05	0.000719	CcSEcCtD
Fluvoxamine—Dehydration—Citalopram—alcohol dependence	7.01e-05	0.000718	CcSEcCtD
Fluvoxamine—Anaemia—Acamprosate—alcohol dependence	7e-05	0.000717	CcSEcCtD
Fluvoxamine—Liver function test abnormal—Citalopram—alcohol dependence	6.96e-05	0.000713	CcSEcCtD
Fluvoxamine—Agitation—Acamprosate—alcohol dependence	6.96e-05	0.000713	CcSEcCtD
Fluvoxamine—Nervousness—Naltrexone—alcohol dependence	6.96e-05	0.000713	CcSEcCtD
Fluvoxamine—CYP2D6—testis—alcohol dependence	6.96e-05	0.00535	CbGeAlD
Fluvoxamine—ABCB1—gonad—alcohol dependence	6.94e-05	0.00534	CbGeAlD
Fluvoxamine—CYP3A4—nervous system—alcohol dependence	6.94e-05	0.00534	CbGeAlD
Fluvoxamine—Back pain—Naltrexone—alcohol dependence	6.93e-05	0.00071	CcSEcCtD
Fluvoxamine—Angioedema—Acamprosate—alcohol dependence	6.92e-05	0.000709	CcSEcCtD
Fluvoxamine—Dry skin—Citalopram—alcohol dependence	6.91e-05	0.000708	CcSEcCtD
Fluvoxamine—Muscle spasms—Naltrexone—alcohol dependence	6.89e-05	0.000706	CcSEcCtD
Fluvoxamine—Orthostatic hypotension—Citalopram—alcohol dependence	6.88e-05	0.000706	CcSEcCtD
Fluvoxamine—Hypokalaemia—Citalopram—alcohol dependence	6.86e-05	0.000703	CcSEcCtD
Fluvoxamine—Malaise—Acamprosate—alcohol dependence	6.83e-05	0.0007	CcSEcCtD
Fluvoxamine—CYP2D6—nervous system—alcohol dependence	6.83e-05	0.00526	CbGeAlD
Fluvoxamine—Breast disorder—Citalopram—alcohol dependence	6.81e-05	0.000698	CcSEcCtD
Fluvoxamine—Vertigo—Acamprosate—alcohol dependence	6.8e-05	0.000697	CcSEcCtD
Fluvoxamine—Syncope—Acamprosate—alcohol dependence	6.79e-05	0.000696	CcSEcCtD
Fluvoxamine—Toxic epidermal necrolysis—Citalopram—alcohol dependence	6.79e-05	0.000696	CcSEcCtD
Fluvoxamine—Leukopenia—Acamprosate—alcohol dependence	6.78e-05	0.000695	CcSEcCtD
Fluvoxamine—Vision blurred—Naltrexone—alcohol dependence	6.75e-05	0.000692	CcSEcCtD
Fluvoxamine—Tremor—Naltrexone—alcohol dependence	6.71e-05	0.000688	CcSEcCtD
Fluvoxamine—Palpitations—Acamprosate—alcohol dependence	6.69e-05	0.000686	CcSEcCtD
Fluvoxamine—CYP3A4—liver—alcohol dependence	6.68e-05	0.00514	CbGeAlD
Fluvoxamine—CYP3A4—central nervous system—alcohol dependence	6.68e-05	0.00514	CbGeAlD
Fluvoxamine—Gastritis—Citalopram—alcohol dependence	6.67e-05	0.000684	CcSEcCtD
Fluvoxamine—Loss of consciousness—Acamprosate—alcohol dependence	6.65e-05	0.000682	CcSEcCtD
Fluvoxamine—Muscular weakness—Citalopram—alcohol dependence	6.65e-05	0.000681	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Naltrexone—alcohol dependence	6.65e-05	0.000681	CcSEcCtD
Fluvoxamine—Cough—Acamprosate—alcohol dependence	6.61e-05	0.000677	CcSEcCtD
Fluvoxamine—CYP2E1—brain—alcohol dependence	6.59e-05	0.00507	CbGeAlD
Fluvoxamine—Agitation—Naltrexone—alcohol dependence	6.58e-05	0.000675	CcSEcCtD
Fluvoxamine—CYP2D6—liver—alcohol dependence	6.58e-05	0.00506	CbGeAlD
Fluvoxamine—CYP2D6—central nervous system—alcohol dependence	6.57e-05	0.00506	CbGeAlD
Fluvoxamine—Convulsion—Acamprosate—alcohol dependence	6.56e-05	0.000672	CcSEcCtD
Fluvoxamine—Abdominal distension—Citalopram—alcohol dependence	6.56e-05	0.000672	CcSEcCtD
Fluvoxamine—Angioedema—Naltrexone—alcohol dependence	6.55e-05	0.000671	CcSEcCtD
Fluvoxamine—Hypertension—Acamprosate—alcohol dependence	6.54e-05	0.00067	CcSEcCtD
Fluvoxamine—Influenza—Citalopram—alcohol dependence	6.51e-05	0.000668	CcSEcCtD
Fluvoxamine—Dysphagia—Citalopram—alcohol dependence	6.51e-05	0.000668	CcSEcCtD
Fluvoxamine—Asthma—Citalopram—alcohol dependence	6.51e-05	0.000668	CcSEcCtD
Fluvoxamine—Malaise—Naltrexone—alcohol dependence	6.46e-05	0.000662	CcSEcCtD
Fluvoxamine—Myalgia—Acamprosate—alcohol dependence	6.45e-05	0.000661	CcSEcCtD
Fluvoxamine—Arthralgia—Acamprosate—alcohol dependence	6.45e-05	0.000661	CcSEcCtD
Fluvoxamine—Chest pain—Acamprosate—alcohol dependence	6.45e-05	0.000661	CcSEcCtD
Fluvoxamine—CYP2D6—cerebellum—alcohol dependence	6.42e-05	0.00495	CbGeAlD
Fluvoxamine—Syncope—Naltrexone—alcohol dependence	6.42e-05	0.000658	CcSEcCtD
Fluvoxamine—Anxiety—Acamprosate—alcohol dependence	6.42e-05	0.000658	CcSEcCtD
Fluvoxamine—Pancreatitis—Citalopram—alcohol dependence	6.39e-05	0.000655	CcSEcCtD
Fluvoxamine—Discomfort—Acamprosate—alcohol dependence	6.37e-05	0.000653	CcSEcCtD
Fluvoxamine—ABCB1—digestive system—alcohol dependence	6.35e-05	0.00489	CbGeAlD
Fluvoxamine—Angina pectoris—Citalopram—alcohol dependence	6.35e-05	0.00065	CcSEcCtD
Fluvoxamine—Sweating increased—Citalopram—alcohol dependence	6.35e-05	0.00065	CcSEcCtD
Fluvoxamine—Palpitations—Naltrexone—alcohol dependence	6.33e-05	0.000649	CcSEcCtD
Fluvoxamine—Dry mouth—Acamprosate—alcohol dependence	6.3e-05	0.000646	CcSEcCtD
Fluvoxamine—Loss of consciousness—Naltrexone—alcohol dependence	6.3e-05	0.000645	CcSEcCtD
Fluvoxamine—Bronchitis—Citalopram—alcohol dependence	6.26e-05	0.000642	CcSEcCtD
Fluvoxamine—Cough—Naltrexone—alcohol dependence	6.25e-05	0.000641	CcSEcCtD
Fluvoxamine—Abdominal discomfort—Citalopram—alcohol dependence	6.25e-05	0.00064	CcSEcCtD
Fluvoxamine—Confusional state—Acamprosate—alcohol dependence	6.23e-05	0.000639	CcSEcCtD
Fluvoxamine—Convulsion—Naltrexone—alcohol dependence	6.21e-05	0.000636	CcSEcCtD
Fluvoxamine—Hypertension—Naltrexone—alcohol dependence	6.18e-05	0.000634	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Acamprosate—alcohol dependence	6.18e-05	0.000633	CcSEcCtD
Fluvoxamine—Infection—Acamprosate—alcohol dependence	6.14e-05	0.000629	CcSEcCtD
Fluvoxamine—Chest pain—Naltrexone—alcohol dependence	6.1e-05	0.000625	CcSEcCtD
Fluvoxamine—Myalgia—Naltrexone—alcohol dependence	6.1e-05	0.000625	CcSEcCtD
Fluvoxamine—Arthralgia—Naltrexone—alcohol dependence	6.1e-05	0.000625	CcSEcCtD
Fluvoxamine—Dysuria—Citalopram—alcohol dependence	6.09e-05	0.000624	CcSEcCtD
Fluvoxamine—Shock—Acamprosate—alcohol dependence	6.08e-05	0.000623	CcSEcCtD
Fluvoxamine—Anxiety—Naltrexone—alcohol dependence	6.08e-05	0.000623	CcSEcCtD
Fluvoxamine—Upper respiratory tract infection—Citalopram—alcohol dependence	6.05e-05	0.000621	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Acamprosate—alcohol dependence	6.05e-05	0.00062	CcSEcCtD
Fluvoxamine—ABCB1—blood—alcohol dependence	6.05e-05	0.00466	CbGeAlD
Fluvoxamine—Tachycardia—Acamprosate—alcohol dependence	6.03e-05	0.000618	CcSEcCtD
Fluvoxamine—Discomfort—Naltrexone—alcohol dependence	6.03e-05	0.000618	CcSEcCtD
Fluvoxamine—Pollakiuria—Citalopram—alcohol dependence	6.02e-05	0.000617	CcSEcCtD
Fluvoxamine—Erectile dysfunction—Citalopram—alcohol dependence	6e-05	0.000615	CcSEcCtD
Fluvoxamine—ABCB1—midbrain—alcohol dependence	5.97e-05	0.0046	CbGeAlD
Fluvoxamine—Hyperhidrosis—Acamprosate—alcohol dependence	5.97e-05	0.000612	CcSEcCtD
Fluvoxamine—Dry mouth—Naltrexone—alcohol dependence	5.96e-05	0.000611	CcSEcCtD
Fluvoxamine—Photosensitivity reaction—Citalopram—alcohol dependence	5.95e-05	0.000609	CcSEcCtD
Fluvoxamine—Weight increased—Citalopram—alcohol dependence	5.93e-05	0.000608	CcSEcCtD
Fluvoxamine—Confusional state—Naltrexone—alcohol dependence	5.9e-05	0.000604	CcSEcCtD
Fluvoxamine—Weight decreased—Citalopram—alcohol dependence	5.89e-05	0.000604	CcSEcCtD
Fluvoxamine—Anorexia—Acamprosate—alcohol dependence	5.89e-05	0.000604	CcSEcCtD
Fluvoxamine—Hyperglycaemia—Citalopram—alcohol dependence	5.88e-05	0.000602	CcSEcCtD
Fluvoxamine—Oedema—Naltrexone—alcohol dependence	5.85e-05	0.000599	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Naltrexone—alcohol dependence	5.85e-05	0.000599	CcSEcCtD
Fluvoxamine—Pneumonia—Citalopram—alcohol dependence	5.84e-05	0.000599	CcSEcCtD
Fluvoxamine—Infection—Naltrexone—alcohol dependence	5.81e-05	0.000595	CcSEcCtD
Fluvoxamine—Depression—Citalopram—alcohol dependence	5.79e-05	0.000594	CcSEcCtD
Fluvoxamine—Hypotension—Acamprosate—alcohol dependence	5.77e-05	0.000592	CcSEcCtD
Fluvoxamine—Stevens-Johnson syndrome—Citalopram—alcohol dependence	5.76e-05	0.00059	CcSEcCtD
Fluvoxamine—Shock—Naltrexone—alcohol dependence	5.75e-05	0.00059	CcSEcCtD
Fluvoxamine—Nervous system disorder—Naltrexone—alcohol dependence	5.73e-05	0.000588	CcSEcCtD
Fluvoxamine—Acute coronary syndrome—Citalopram—alcohol dependence	5.73e-05	0.000587	CcSEcCtD
Fluvoxamine—Tachycardia—Naltrexone—alcohol dependence	5.71e-05	0.000585	CcSEcCtD
Fluvoxamine—Myocardial infarction—Citalopram—alcohol dependence	5.69e-05	0.000584	CcSEcCtD
Fluvoxamine—Neuropathy peripheral—Citalopram—alcohol dependence	5.69e-05	0.000584	CcSEcCtD
Fluvoxamine—Jaundice—Citalopram—alcohol dependence	5.66e-05	0.00058	CcSEcCtD
Fluvoxamine—Stomatitis—Citalopram—alcohol dependence	5.66e-05	0.00058	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Naltrexone—alcohol dependence	5.65e-05	0.000579	CcSEcCtD
Fluvoxamine—Urinary tract infection—Citalopram—alcohol dependence	5.65e-05	0.000579	CcSEcCtD
Fluvoxamine—Conjunctivitis—Citalopram—alcohol dependence	5.65e-05	0.000579	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Acamprosate—alcohol dependence	5.63e-05	0.000577	CcSEcCtD
Fluvoxamine—Insomnia—Acamprosate—alcohol dependence	5.59e-05	0.000573	CcSEcCtD
Fluvoxamine—Anorexia—Naltrexone—alcohol dependence	5.57e-05	0.000571	CcSEcCtD
Fluvoxamine—Sweating—Citalopram—alcohol dependence	5.57e-05	0.000571	CcSEcCtD
Fluvoxamine—Paraesthesia—Acamprosate—alcohol dependence	5.55e-05	0.000569	CcSEcCtD
Fluvoxamine—Haematuria—Citalopram—alcohol dependence	5.54e-05	0.000568	CcSEcCtD
Fluvoxamine—Dyspnoea—Acamprosate—alcohol dependence	5.51e-05	0.000565	CcSEcCtD
Fluvoxamine—Somnolence—Acamprosate—alcohol dependence	5.49e-05	0.000563	CcSEcCtD
Fluvoxamine—Hepatobiliary disease—Citalopram—alcohol dependence	5.49e-05	0.000563	CcSEcCtD
Fluvoxamine—Epistaxis—Citalopram—alcohol dependence	5.48e-05	0.000561	CcSEcCtD
Fluvoxamine—Sinusitis—Citalopram—alcohol dependence	5.45e-05	0.000558	CcSEcCtD
Fluvoxamine—Dyspepsia—Acamprosate—alcohol dependence	5.44e-05	0.000557	CcSEcCtD
Fluvoxamine—Agranulocytosis—Citalopram—alcohol dependence	5.42e-05	0.000556	CcSEcCtD
Fluvoxamine—Decreased appetite—Acamprosate—alcohol dependence	5.37e-05	0.000551	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Acamprosate—alcohol dependence	5.33e-05	0.000547	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Naltrexone—alcohol dependence	5.33e-05	0.000546	CcSEcCtD
Fluvoxamine—Bradycardia—Citalopram—alcohol dependence	5.31e-05	0.000544	CcSEcCtD
Fluvoxamine—Insomnia—Naltrexone—alcohol dependence	5.29e-05	0.000542	CcSEcCtD
Fluvoxamine—Constipation—Acamprosate—alcohol dependence	5.28e-05	0.000542	CcSEcCtD
Fluvoxamine—Pain—Acamprosate—alcohol dependence	5.28e-05	0.000542	CcSEcCtD
Fluvoxamine—Paraesthesia—Naltrexone—alcohol dependence	5.25e-05	0.000538	CcSEcCtD
Fluvoxamine—ABCB1—endocrine gland—alcohol dependence	5.25e-05	0.00404	CbGeAlD
Fluvoxamine—Haemoglobin—Citalopram—alcohol dependence	5.24e-05	0.000537	CcSEcCtD
Fluvoxamine—Rhinitis—Citalopram—alcohol dependence	5.23e-05	0.000536	CcSEcCtD
Fluvoxamine—CYP2D6—brain—alcohol dependence	5.22e-05	0.00402	CbGeAlD
Fluvoxamine—Haemorrhage—Citalopram—alcohol dependence	5.21e-05	0.000534	CcSEcCtD
Fluvoxamine—Hepatitis—Citalopram—alcohol dependence	5.21e-05	0.000534	CcSEcCtD
Fluvoxamine—Dyspnoea—Naltrexone—alcohol dependence	5.21e-05	0.000534	CcSEcCtD
Fluvoxamine—Somnolence—Naltrexone—alcohol dependence	5.2e-05	0.000533	CcSEcCtD
Fluvoxamine—Hypoaesthesia—Citalopram—alcohol dependence	5.19e-05	0.000532	CcSEcCtD
Fluvoxamine—Hallucination—Citalopram—alcohol dependence	5.19e-05	0.000532	CcSEcCtD
Fluvoxamine—Pharyngitis—Citalopram—alcohol dependence	5.18e-05	0.00053	CcSEcCtD
Fluvoxamine—Urinary tract disorder—Citalopram—alcohol dependence	5.15e-05	0.000528	CcSEcCtD
Fluvoxamine—Oedema peripheral—Citalopram—alcohol dependence	5.14e-05	0.000526	CcSEcCtD
Fluvoxamine—Urethral disorder—Citalopram—alcohol dependence	5.11e-05	0.000524	CcSEcCtD
Fluvoxamine—Feeling abnormal—Acamprosate—alcohol dependence	5.09e-05	0.000522	CcSEcCtD
Fluvoxamine—Decreased appetite—Naltrexone—alcohol dependence	5.08e-05	0.000521	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Acamprosate—alcohol dependence	5.05e-05	0.000518	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Naltrexone—alcohol dependence	5.05e-05	0.000517	CcSEcCtD
Fluvoxamine—Fatigue—Naltrexone—alcohol dependence	5.04e-05	0.000517	CcSEcCtD
Fluvoxamine—Visual impairment—Citalopram—alcohol dependence	5.02e-05	0.000515	CcSEcCtD
Fluvoxamine—ABCB1—testis—alcohol dependence	5e-05	0.00385	CbGeAlD
Fluvoxamine—Pain—Naltrexone—alcohol dependence	5e-05	0.000512	CcSEcCtD
Fluvoxamine—Constipation—Naltrexone—alcohol dependence	5e-05	0.000512	CcSEcCtD
Fluvoxamine—Erythema multiforme—Citalopram—alcohol dependence	4.93e-05	0.000505	CcSEcCtD
Fluvoxamine—ABCB1—nervous system—alcohol dependence	4.91e-05	0.00378	CbGeAlD
Fluvoxamine—Urticaria—Acamprosate—alcohol dependence	4.91e-05	0.000503	CcSEcCtD
Fluvoxamine—Abdominal pain—Acamprosate—alcohol dependence	4.88e-05	0.000501	CcSEcCtD
Fluvoxamine—Body temperature increased—Acamprosate—alcohol dependence	4.88e-05	0.000501	CcSEcCtD
Fluvoxamine—Eye disorder—Citalopram—alcohol dependence	4.87e-05	0.000499	CcSEcCtD
Fluvoxamine—Tinnitus—Citalopram—alcohol dependence	4.86e-05	0.000498	CcSEcCtD
Fluvoxamine—Cardiac disorder—Citalopram—alcohol dependence	4.84e-05	0.000496	CcSEcCtD
Fluvoxamine—Feeling abnormal—Naltrexone—alcohol dependence	4.82e-05	0.000494	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Naltrexone—alcohol dependence	4.78e-05	0.00049	CcSEcCtD
Fluvoxamine—ABCB1—liver—alcohol dependence	4.73e-05	0.00364	CbGeAlD
Fluvoxamine—Angiopathy—Citalopram—alcohol dependence	4.73e-05	0.000485	CcSEcCtD
Fluvoxamine—ABCB1—central nervous system—alcohol dependence	4.73e-05	0.00364	CbGeAlD
Fluvoxamine—Chills—Citalopram—alcohol dependence	4.68e-05	0.000479	CcSEcCtD
Fluvoxamine—Arrhythmia—Citalopram—alcohol dependence	4.66e-05	0.000477	CcSEcCtD
Fluvoxamine—Urticaria—Naltrexone—alcohol dependence	4.64e-05	0.000476	CcSEcCtD
Fluvoxamine—Abdominal pain—Naltrexone—alcohol dependence	4.62e-05	0.000474	CcSEcCtD
Fluvoxamine—Body temperature increased—Naltrexone—alcohol dependence	4.62e-05	0.000474	CcSEcCtD
Fluvoxamine—ABCB1—cerebellum—alcohol dependence	4.62e-05	0.00356	CbGeAlD
Fluvoxamine—Alopecia—Citalopram—alcohol dependence	4.61e-05	0.000472	CcSEcCtD
Fluvoxamine—Mental disorder—Citalopram—alcohol dependence	4.57e-05	0.000468	CcSEcCtD
Fluvoxamine—Hypersensitivity—Acamprosate—alcohol dependence	4.55e-05	0.000467	CcSEcCtD
Fluvoxamine—Malnutrition—Citalopram—alcohol dependence	4.54e-05	0.000465	CcSEcCtD
Fluvoxamine—Flatulence—Citalopram—alcohol dependence	4.47e-05	0.000458	CcSEcCtD
Fluvoxamine—Tension—Citalopram—alcohol dependence	4.45e-05	0.000456	CcSEcCtD
Fluvoxamine—Dysgeusia—Citalopram—alcohol dependence	4.44e-05	0.000456	CcSEcCtD
Fluvoxamine—Asthenia—Acamprosate—alcohol dependence	4.43e-05	0.000454	CcSEcCtD
Fluvoxamine—Nervousness—Citalopram—alcohol dependence	4.41e-05	0.000452	CcSEcCtD
Fluvoxamine—Back pain—Citalopram—alcohol dependence	4.39e-05	0.00045	CcSEcCtD
Fluvoxamine—Pruritus—Acamprosate—alcohol dependence	4.37e-05	0.000448	CcSEcCtD
Fluvoxamine—Muscle spasms—Citalopram—alcohol dependence	4.36e-05	0.000447	CcSEcCtD
Fluvoxamine—Hypersensitivity—Naltrexone—alcohol dependence	4.31e-05	0.000441	CcSEcCtD
Fluvoxamine—Vision blurred—Citalopram—alcohol dependence	4.28e-05	0.000438	CcSEcCtD
Fluvoxamine—Tremor—Citalopram—alcohol dependence	4.25e-05	0.000436	CcSEcCtD
Fluvoxamine—Diarrhoea—Acamprosate—alcohol dependence	4.23e-05	0.000433	CcSEcCtD
Fluvoxamine—Ill-defined disorder—Citalopram—alcohol dependence	4.21e-05	0.000432	CcSEcCtD
Fluvoxamine—Anaemia—Citalopram—alcohol dependence	4.2e-05	0.00043	CcSEcCtD
Fluvoxamine—Asthenia—Naltrexone—alcohol dependence	4.19e-05	0.00043	CcSEcCtD
Fluvoxamine—Agitation—Citalopram—alcohol dependence	4.17e-05	0.000428	CcSEcCtD
Fluvoxamine—Angioedema—Citalopram—alcohol dependence	4.15e-05	0.000425	CcSEcCtD
Fluvoxamine—Pruritus—Naltrexone—alcohol dependence	4.14e-05	0.000424	CcSEcCtD
Fluvoxamine—Malaise—Citalopram—alcohol dependence	4.09e-05	0.00042	CcSEcCtD
Fluvoxamine—Dizziness—Acamprosate—alcohol dependence	4.09e-05	0.000419	CcSEcCtD
Fluvoxamine—Vertigo—Citalopram—alcohol dependence	4.08e-05	0.000418	CcSEcCtD
Fluvoxamine—Syncope—Citalopram—alcohol dependence	4.07e-05	0.000417	CcSEcCtD
Fluvoxamine—Leukopenia—Citalopram—alcohol dependence	4.06e-05	0.000416	CcSEcCtD
Fluvoxamine—Palpitations—Citalopram—alcohol dependence	4.01e-05	0.000411	CcSEcCtD
Fluvoxamine—Diarrhoea—Naltrexone—alcohol dependence	4e-05	0.00041	CcSEcCtD
Fluvoxamine—Loss of consciousness—Citalopram—alcohol dependence	3.99e-05	0.000409	CcSEcCtD
Fluvoxamine—Cough—Citalopram—alcohol dependence	3.96e-05	0.000406	CcSEcCtD
Fluvoxamine—Convulsion—Citalopram—alcohol dependence	3.93e-05	0.000403	CcSEcCtD
Fluvoxamine—Vomiting—Acamprosate—alcohol dependence	3.93e-05	0.000403	CcSEcCtD
Fluvoxamine—Hypertension—Citalopram—alcohol dependence	3.92e-05	0.000402	CcSEcCtD
Fluvoxamine—Rash—Acamprosate—alcohol dependence	3.9e-05	0.000399	CcSEcCtD
Fluvoxamine—Dermatitis—Acamprosate—alcohol dependence	3.89e-05	0.000399	CcSEcCtD
Fluvoxamine—Headache—Acamprosate—alcohol dependence	3.87e-05	0.000397	CcSEcCtD
Fluvoxamine—Dizziness—Naltrexone—alcohol dependence	3.87e-05	0.000396	CcSEcCtD
Fluvoxamine—Chest pain—Citalopram—alcohol dependence	3.86e-05	0.000396	CcSEcCtD
Fluvoxamine—Arthralgia—Citalopram—alcohol dependence	3.86e-05	0.000396	CcSEcCtD
Fluvoxamine—Myalgia—Citalopram—alcohol dependence	3.86e-05	0.000396	CcSEcCtD
Fluvoxamine—Anxiety—Citalopram—alcohol dependence	3.85e-05	0.000395	CcSEcCtD
Fluvoxamine—Discomfort—Citalopram—alcohol dependence	3.82e-05	0.000391	CcSEcCtD
Fluvoxamine—Dry mouth—Citalopram—alcohol dependence	3.78e-05	0.000387	CcSEcCtD
Fluvoxamine—ABCB1—brain—alcohol dependence	3.75e-05	0.00289	CbGeAlD
Fluvoxamine—Confusional state—Citalopram—alcohol dependence	3.74e-05	0.000383	CcSEcCtD
Fluvoxamine—Vomiting—Naltrexone—alcohol dependence	3.72e-05	0.000381	CcSEcCtD
Fluvoxamine—Oedema—Citalopram—alcohol dependence	3.7e-05	0.00038	CcSEcCtD
Fluvoxamine—Anaphylactic shock—Citalopram—alcohol dependence	3.7e-05	0.00038	CcSEcCtD
Fluvoxamine—Rash—Naltrexone—alcohol dependence	3.69e-05	0.000378	CcSEcCtD
Fluvoxamine—Dermatitis—Naltrexone—alcohol dependence	3.68e-05	0.000377	CcSEcCtD
Fluvoxamine—Infection—Citalopram—alcohol dependence	3.68e-05	0.000377	CcSEcCtD
Fluvoxamine—Nausea—Acamprosate—alcohol dependence	3.67e-05	0.000376	CcSEcCtD
Fluvoxamine—Headache—Naltrexone—alcohol dependence	3.66e-05	0.000375	CcSEcCtD
Fluvoxamine—Shock—Citalopram—alcohol dependence	3.64e-05	0.000374	CcSEcCtD
Fluvoxamine—Nervous system disorder—Citalopram—alcohol dependence	3.63e-05	0.000372	CcSEcCtD
Fluvoxamine—Thrombocytopenia—Citalopram—alcohol dependence	3.63e-05	0.000372	CcSEcCtD
Fluvoxamine—Tachycardia—Citalopram—alcohol dependence	3.62e-05	0.000371	CcSEcCtD
Fluvoxamine—Hyperhidrosis—Citalopram—alcohol dependence	3.58e-05	0.000367	CcSEcCtD
Fluvoxamine—Anorexia—Citalopram—alcohol dependence	3.53e-05	0.000362	CcSEcCtD
Fluvoxamine—Nausea—Naltrexone—alcohol dependence	3.47e-05	0.000356	CcSEcCtD
Fluvoxamine—Hypotension—Citalopram—alcohol dependence	3.46e-05	0.000355	CcSEcCtD
Fluvoxamine—Musculoskeletal discomfort—Citalopram—alcohol dependence	3.38e-05	0.000346	CcSEcCtD
Fluvoxamine—Insomnia—Citalopram—alcohol dependence	3.35e-05	0.000343	CcSEcCtD
Fluvoxamine—Paraesthesia—Citalopram—alcohol dependence	3.33e-05	0.000341	CcSEcCtD
Fluvoxamine—Dyspnoea—Citalopram—alcohol dependence	3.3e-05	0.000338	CcSEcCtD
Fluvoxamine—Somnolence—Citalopram—alcohol dependence	3.29e-05	0.000338	CcSEcCtD
Fluvoxamine—Dyspepsia—Citalopram—alcohol dependence	3.26e-05	0.000334	CcSEcCtD
Fluvoxamine—Decreased appetite—Citalopram—alcohol dependence	3.22e-05	0.00033	CcSEcCtD
Fluvoxamine—Gastrointestinal disorder—Citalopram—alcohol dependence	3.2e-05	0.000328	CcSEcCtD
Fluvoxamine—Fatigue—Citalopram—alcohol dependence	3.19e-05	0.000327	CcSEcCtD
Fluvoxamine—Constipation—Citalopram—alcohol dependence	3.17e-05	0.000325	CcSEcCtD
Fluvoxamine—Pain—Citalopram—alcohol dependence	3.17e-05	0.000325	CcSEcCtD
Fluvoxamine—Feeling abnormal—Citalopram—alcohol dependence	3.05e-05	0.000313	CcSEcCtD
Fluvoxamine—Gastrointestinal pain—Citalopram—alcohol dependence	3.03e-05	0.00031	CcSEcCtD
Fluvoxamine—Urticaria—Citalopram—alcohol dependence	2.94e-05	0.000302	CcSEcCtD
Fluvoxamine—Body temperature increased—Citalopram—alcohol dependence	2.93e-05	0.0003	CcSEcCtD
Fluvoxamine—Abdominal pain—Citalopram—alcohol dependence	2.93e-05	0.0003	CcSEcCtD
Fluvoxamine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	2.79e-05	0.000664	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metapathway biotransformation—CYP2E1—alcohol dependence	2.78e-05	0.000663	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—GGT1—alcohol dependence	2.75e-05	0.000655	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—GGT1—alcohol dependence	2.74e-05	0.000653	CbGpPWpGaD
Fluvoxamine—Hypersensitivity—Citalopram—alcohol dependence	2.73e-05	0.00028	CcSEcCtD
Fluvoxamine—CYP3A4—Biological oxidations—GGT2—alcohol dependence	2.7e-05	0.000642	CbGpPWpGaD
Fluvoxamine—Asthenia—Citalopram—alcohol dependence	2.66e-05	0.000272	CcSEcCtD
Fluvoxamine—CYP2D6—Biological oxidations—ALDH2—alcohol dependence	2.66e-05	0.000633	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—MAOB—alcohol dependence	2.65e-05	0.000631	CbGpPWpGaD
Fluvoxamine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	2.64e-05	0.000629	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—ALDH2—alcohol dependence	2.63e-05	0.000628	CbGpPWpGaD
Fluvoxamine—SLC6A3—SLC-mediated transmembrane transport—AVP—alcohol dependence	2.63e-05	0.000626	CbGpPWpGaD
Fluvoxamine—Pruritus—Citalopram—alcohol dependence	2.62e-05	0.000269	CcSEcCtD
Fluvoxamine—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	2.62e-05	0.000624	CbGpPWpGaD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—alcohol dependence	2.61e-05	0.000623	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—GGT1—alcohol dependence	2.59e-05	0.000617	CbGpPWpGaD
Fluvoxamine—Diarrhoea—Citalopram—alcohol dependence	2.53e-05	0.00026	CcSEcCtD
Fluvoxamine—SLC6A3—Neuronal System—MAOA—alcohol dependence	2.53e-05	0.000604	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—MAOA—alcohol dependence	2.51e-05	0.000599	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—ADH1B—alcohol dependence	2.47e-05	0.000587	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—MAOA—alcohol dependence	2.46e-05	0.000587	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—MAOA—alcohol dependence	2.46e-05	0.000586	CbGpPWpGaD
Fluvoxamine—Dizziness—Citalopram—alcohol dependence	2.45e-05	0.000251	CcSEcCtD
Fluvoxamine—CYP3A7—Metabolism—ADH6—alcohol dependence	2.39e-05	0.000569	CbGpPWpGaD
Fluvoxamine—Vomiting—Citalopram—alcohol dependence	2.36e-05	0.000241	CcSEcCtD
Fluvoxamine—Rash—Citalopram—alcohol dependence	2.34e-05	0.000239	CcSEcCtD
Fluvoxamine—Dermatitis—Citalopram—alcohol dependence	2.33e-05	0.000239	CcSEcCtD
Fluvoxamine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	2.33e-05	0.000555	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—MAOA—alcohol dependence	2.32e-05	0.000553	CbGpPWpGaD
Fluvoxamine—Headache—Citalopram—alcohol dependence	2.32e-05	0.000238	CcSEcCtD
Fluvoxamine—CYP2C19—Biological oxidations—CYP2E1—alcohol dependence	2.31e-05	0.00055	CbGpPWpGaD
Fluvoxamine—SLC6A4—SIDS Susceptibility Pathways—EP300—alcohol dependence	2.29e-05	0.000545	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metapathway biotransformation—CYP2E1—alcohol dependence	2.28e-05	0.000543	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—ALDH2—alcohol dependence	2.25e-05	0.000536	CbGpPWpGaD
Fluvoxamine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	2.24e-05	0.000533	CbGpPWpGaD
Fluvoxamine—CYP3A7—Biological oxidations—POMC—alcohol dependence	2.21e-05	0.000527	CbGpPWpGaD
Fluvoxamine—Nausea—Citalopram—alcohol dependence	2.2e-05	0.000226	CcSEcCtD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—alcohol dependence	2.15e-05	0.000512	CbGpPWpGaD
Fluvoxamine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	2.14e-05	0.00051	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—CYP2E1—alcohol dependence	2.12e-05	0.000506	CbGpPWpGaD
Fluvoxamine—CYP2C9—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	2.12e-05	0.000506	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—GGT1—alcohol dependence	2.12e-05	0.000505	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—CYP2E1—alcohol dependence	2.11e-05	0.000502	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metapathway biotransformation—CYP2E1—alcohol dependence	2.1e-05	0.000499	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metapathway biotransformation—CYP2E1—alcohol dependence	2.08e-05	0.000495	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—MAOB—alcohol dependence	2.04e-05	0.000487	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ADH1A—alcohol dependence	1.98e-05	0.000471	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—GGT1—alcohol dependence	1.95e-05	0.000465	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—GGT1—alcohol dependence	1.93e-05	0.000461	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—MAOA—alcohol dependence	1.9e-05	0.000453	CbGpPWpGaD
Fluvoxamine—SLC6A4—Circadian rythm related genes—EP300—alcohol dependence	1.87e-05	0.000445	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—alcohol dependence	1.84e-05	0.000438	CbGpPWpGaD
Fluvoxamine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—alcohol dependence	1.84e-05	0.000438	CbGpPWpGaD
Fluvoxamine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	1.81e-05	0.000432	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—CYP2E1—alcohol dependence	1.8e-05	0.000429	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metapathway biotransformation—CYP2E1—alcohol dependence	1.77e-05	0.000423	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ADH6—alcohol dependence	1.77e-05	0.000421	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—MAOA—alcohol dependence	1.75e-05	0.000416	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—ALDH2—alcohol dependence	1.74e-05	0.000414	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—MAOA—alcohol dependence	1.73e-05	0.000413	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ADH6—alcohol dependence	1.73e-05	0.000412	CbGpPWpGaD
Fluvoxamine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—alcohol dependence	1.73e-05	0.000412	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ADH6—alcohol dependence	1.73e-05	0.000411	CbGpPWpGaD
Fluvoxamine—ABCB1—HIF-1-alpha transcription factor network—EP300—alcohol dependence	1.72e-05	0.000411	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ADH4—alcohol dependence	1.68e-05	0.000401	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—GABRB1—alcohol dependence	1.67e-05	0.000397	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—GGT1—alcohol dependence	1.65e-05	0.000394	CbGpPWpGaD
Fluvoxamine—CYP2B6—Biological oxidations—POMC—alcohol dependence	1.64e-05	0.00039	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ADH6—alcohol dependence	1.63e-05	0.000389	CbGpPWpGaD
Fluvoxamine—CYP2E1—Biological oxidations—POMC—alcohol dependence	1.6e-05	0.000382	CbGpPWpGaD
Fluvoxamine—CYP3A5—Biological oxidations—POMC—alcohol dependence	1.6e-05	0.000381	CbGpPWpGaD
Fluvoxamine—CYP1A1—Biological oxidations—POMC—alcohol dependence	1.51e-05	0.00036	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—MAOA—alcohol dependence	1.48e-05	0.000353	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ADH1A—alcohol dependence	1.46e-05	0.000349	CbGpPWpGaD
Fluvoxamine—CYP1A1—PPARA activates gene expression—EP300—alcohol dependence	1.43e-05	0.000342	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ADH1A—alcohol dependence	1.43e-05	0.000342	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ADH7—alcohol dependence	1.43e-05	0.000341	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ADH1A—alcohol dependence	1.43e-05	0.000341	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—GABRA2—alcohol dependence	1.42e-05	0.000338	CbGpPWpGaD
Fluvoxamine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—alcohol dependence	1.4e-05	0.000334	CbGpPWpGaD
Fluvoxamine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—alcohol dependence	1.4e-05	0.000334	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—CYP2E1—alcohol dependence	1.39e-05	0.000331	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GGT2—alcohol dependence	1.37e-05	0.000327	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metapathway biotransformation—CYP2E1—alcohol dependence	1.37e-05	0.000326	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ADH1A—alcohol dependence	1.35e-05	0.000322	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ADH6—alcohol dependence	1.34e-05	0.000318	CbGpPWpGaD
Fluvoxamine—SLC6A3—Transmembrane transport of small molecules—AVP—alcohol dependence	1.33e-05	0.000318	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ADH6—alcohol dependence	1.3e-05	0.00031	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—GGT1—alcohol dependence	1.28e-05	0.000304	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ADH1B—alcohol dependence	1.25e-05	0.000299	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ADH4—alcohol dependence	1.24e-05	0.000296	CbGpPWpGaD
Fluvoxamine—CYP2C19—Biological oxidations—POMC—alcohol dependence	1.24e-05	0.000295	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ADH6—alcohol dependence	1.23e-05	0.000292	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ADH4—alcohol dependence	1.22e-05	0.00029	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ADH6—alcohol dependence	1.22e-05	0.00029	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ADH4—alcohol dependence	1.22e-05	0.00029	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ADH4—alcohol dependence	1.15e-05	0.000274	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—MAOA—alcohol dependence	1.14e-05	0.000272	CbGpPWpGaD
Fluvoxamine—CYP2D6—Biological oxidations—POMC—alcohol dependence	1.14e-05	0.000271	CbGpPWpGaD
Fluvoxamine—CYP2C9—Biological oxidations—POMC—alcohol dependence	1.13e-05	0.000269	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ADH1A—alcohol dependence	1.11e-05	0.000263	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ADH1A—alcohol dependence	1.08e-05	0.000257	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ADH7—alcohol dependence	1.06e-05	0.000252	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ADH6—alcohol dependence	1.04e-05	0.000248	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MAOB—alcohol dependence	1.04e-05	0.000248	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ADH7—alcohol dependence	1.04e-05	0.000247	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ADH7—alcohol dependence	1.03e-05	0.000246	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ADH1A—alcohol dependence	1.02e-05	0.000242	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GGT2—alcohol dependence	1.01e-05	0.000242	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ADH1A—alcohol dependence	1.01e-05	0.00024	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	9.95e-06	0.000237	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GGT2—alcohol dependence	9.94e-06	0.000237	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GGT2—alcohol dependence	9.92e-06	0.000236	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ADH7—alcohol dependence	9.77e-06	0.000233	CbGpPWpGaD
Fluvoxamine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—alcohol dependence	9.67e-06	0.00023	CbGpPWpGaD
Fluvoxamine—CYP1A2—Biological oxidations—POMC—alcohol dependence	9.64e-06	0.00023	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ADH4—alcohol dependence	9.41e-06	0.000224	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GGT2—alcohol dependence	9.37e-06	0.000223	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ADH1B—alcohol dependence	9.28e-06	0.000221	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ADH4—alcohol dependence	9.18e-06	0.000219	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ADH1B—alcohol dependence	9.09e-06	0.000217	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ADH1B—alcohol dependence	9.07e-06	0.000216	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—ALDH2—alcohol dependence	8.84e-06	0.000211	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ADH4—alcohol dependence	8.65e-06	0.000206	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ADH1A—alcohol dependence	8.62e-06	0.000205	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ADH4—alcohol dependence	8.58e-06	0.000204	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ADH1B—alcohol dependence	8.57e-06	0.000204	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	8.14e-06	0.000194	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ADH6—alcohol dependence	8.03e-06	0.000191	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—SLC6A3—alcohol dependence	8.02e-06	0.000191	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ADH7—alcohol dependence	8e-06	0.000191	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ADH7—alcohol dependence	7.81e-06	0.000186	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MAOB—alcohol dependence	7.69e-06	0.000183	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GGT2—alcohol dependence	7.67e-06	0.000183	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MAOB—alcohol dependence	7.53e-06	0.000179	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GOT2—alcohol dependence	7.52e-06	0.000179	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MAOB—alcohol dependence	7.52e-06	0.000179	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GGT2—alcohol dependence	7.48e-06	0.000178	CbGpPWpGaD
Fluvoxamine—CYP3A4—Biological oxidations—POMC—alcohol dependence	7.44e-06	0.000177	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	7.43e-06	0.000177	CbGpPWpGaD
Fluvoxamine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	7.37e-06	0.000175	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ADH7—alcohol dependence	7.36e-06	0.000175	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ADH4—alcohol dependence	7.33e-06	0.000175	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ADH7—alcohol dependence	7.29e-06	0.000174	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MAOB—alcohol dependence	7.1e-06	0.000169	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—CYP2E1—alcohol dependence	7.07e-06	0.000168	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GGT2—alcohol dependence	7.05e-06	0.000168	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ADH1B—alcohol dependence	7.01e-06	0.000167	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GGT2—alcohol dependence	6.99e-06	0.000167	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ADH1B—alcohol dependence	6.84e-06	0.000163	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ADH1A—alcohol dependence	6.65e-06	0.000158	CbGpPWpGaD
Fluvoxamine—ABCB1—Transmembrane transport of small molecules—AVP—alcohol dependence	6.64e-06	0.000158	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—ALDH2—alcohol dependence	6.54e-06	0.000156	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GGT1—alcohol dependence	6.49e-06	0.000155	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—GOT1—alcohol dependence	6.49e-06	0.000155	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ADH1B—alcohol dependence	6.45e-06	0.000154	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—ALDH2—alcohol dependence	6.4e-06	0.000153	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ADH1B—alcohol dependence	6.39e-06	0.000152	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—ALDH2—alcohol dependence	6.39e-06	0.000152	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—alcohol dependence	6.35e-06	0.000151	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ADH7—alcohol dependence	6.23e-06	0.000148	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—ALDH2—alcohol dependence	6.04e-06	0.000144	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GGT2—alcohol dependence	5.97e-06	0.000142	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—MAOA—alcohol dependence	5.82e-06	0.000139	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MAOB—alcohol dependence	5.81e-06	0.000138	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	5.81e-06	0.000138	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MAOB—alcohol dependence	5.67e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ADH4—alcohol dependence	5.66e-06	0.000135	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GOT2—alcohol dependence	5.56e-06	0.000132	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ADH1B—alcohol dependence	5.46e-06	0.00013	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GOT2—alcohol dependence	5.45e-06	0.00013	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GOT2—alcohol dependence	5.43e-06	0.000129	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MAOB—alcohol dependence	5.34e-06	0.000127	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MAOB—alcohol dependence	5.3e-06	0.000126	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—CYP2E1—alcohol dependence	5.23e-06	0.000125	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GOT2—alcohol dependence	5.13e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—CYP2E1—alcohol dependence	5.11e-06	0.000122	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—ALDH2—alcohol dependence	4.94e-06	0.000118	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—CYP2E1—alcohol dependence	4.83e-06	0.000115	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—ALDH2—alcohol dependence	4.82e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ADH7—alcohol dependence	4.81e-06	0.000115	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GOT1—alcohol dependence	4.8e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—GGT1—alcohol dependence	4.8e-06	0.000114	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.75e-06	0.000113	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GOT1—alcohol dependence	4.7e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—GGT1—alcohol dependence	4.7e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GGT1—alcohol dependence	4.69e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—GOT1—alcohol dependence	4.69e-06	0.000112	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GGT2—alcohol dependence	4.61e-06	0.00011	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—ALDH2—alcohol dependence	4.54e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MAOB—alcohol dependence	4.53e-06	0.000108	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—ALDH2—alcohol dependence	4.51e-06	0.000107	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GGT1—alcohol dependence	4.43e-06	0.000106	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—GOT1—alcohol dependence	4.43e-06	0.000106	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	4.33e-06	0.000103	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—MAOA—alcohol dependence	4.3e-06	0.000102	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ADH1B—alcohol dependence	4.22e-06	0.0001	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—MAOA—alcohol dependence	4.21e-06	0.0001	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—MAOA—alcohol dependence	4.2e-06	0.0001	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GOT2—alcohol dependence	4.2e-06	0.0001	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GOT2—alcohol dependence	4.1e-06	9.77e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—MAOA—alcohol dependence	3.97e-06	9.46e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—CYP2E1—alcohol dependence	3.95e-06	9.41e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GOT2—alcohol dependence	3.86e-06	9.2e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—CYP2E1—alcohol dependence	3.86e-06	9.18e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.85e-06	9.17e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—ALDH2—alcohol dependence	3.85e-06	9.17e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GOT2—alcohol dependence	3.83e-06	9.12e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—POMC—alcohol dependence	3.79e-06	9.02e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—alcohol dependence	3.7e-06	8.82e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—CYP2E1—alcohol dependence	3.63e-06	8.65e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GOT1—alcohol dependence	3.63e-06	8.64e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—GGT1—alcohol dependence	3.63e-06	8.64e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—CYP2E1—alcohol dependence	3.6e-06	8.58e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GGT1—alcohol dependence	3.54e-06	8.43e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—GOT1—alcohol dependence	3.54e-06	8.43e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MAOB—alcohol dependence	3.49e-06	8.32e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GOT1—alcohol dependence	3.34e-06	7.95e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—GGT1—alcohol dependence	3.34e-06	7.95e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GGT1—alcohol dependence	3.31e-06	7.88e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—GOT1—alcohol dependence	3.31e-06	7.88e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GOT2—alcohol dependence	3.27e-06	7.8e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—MAOA—alcohol dependence	3.25e-06	7.74e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—MAOA—alcohol dependence	3.17e-06	7.56e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	3.15e-06	7.51e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—CYP2E1—alcohol dependence	3.08e-06	7.33e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—MAOA—alcohol dependence	2.99e-06	7.12e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—ALDH2—alcohol dependence	2.97e-06	7.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—MAOA—alcohol dependence	2.96e-06	7.06e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.87e-06	6.85e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GGT1—alcohol dependence	2.83e-06	6.73e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—GOT1—alcohol dependence	2.83e-06	6.73e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—POMC—alcohol dependence	2.8e-06	6.67e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—POMC—alcohol dependence	2.74e-06	6.53e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—POMC—alcohol dependence	2.74e-06	6.52e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—POMC—alcohol dependence	2.59e-06	6.16e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—MAOA—alcohol dependence	2.53e-06	6.03e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GOT2—alcohol dependence	2.53e-06	6.02e-05	CbGpPWpGaD
Fluvoxamine—CYP3A7—Metabolism—EP300—alcohol dependence	2.51e-06	5.98e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—alcohol dependence	2.46e-06	5.85e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—CYP2E1—alcohol dependence	2.38e-06	5.66e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GGT1—alcohol dependence	2.18e-06	5.19e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—GOT1—alcohol dependence	2.18e-06	5.19e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—POMC—alcohol dependence	2.12e-06	5.04e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—POMC—alcohol dependence	2.07e-06	4.92e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—MAOA—alcohol dependence	1.95e-06	4.66e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—POMC—alcohol dependence	1.95e-06	4.64e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—POMC—alcohol dependence	1.93e-06	4.6e-05	CbGpPWpGaD
Fluvoxamine—CYP2B6—Metabolism—EP300—alcohol dependence	1.86e-06	4.42e-05	CbGpPWpGaD
Fluvoxamine—CYP2E1—Metabolism—EP300—alcohol dependence	1.82e-06	4.33e-05	CbGpPWpGaD
Fluvoxamine—CYP3A5—Metabolism—EP300—alcohol dependence	1.82e-06	4.32e-05	CbGpPWpGaD
Fluvoxamine—CYP1A1—Metabolism—EP300—alcohol dependence	1.72e-06	4.09e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—POMC—alcohol dependence	1.65e-06	3.93e-05	CbGpPWpGaD
Fluvoxamine—CYP2C19—Metabolism—EP300—alcohol dependence	1.4e-06	3.34e-05	CbGpPWpGaD
Fluvoxamine—ABCB1—Metabolism—EP300—alcohol dependence	1.37e-06	3.26e-05	CbGpPWpGaD
Fluvoxamine—CYP2D6—Metabolism—EP300—alcohol dependence	1.29e-06	3.08e-05	CbGpPWpGaD
Fluvoxamine—CYP2C9—Metabolism—EP300—alcohol dependence	1.28e-06	3.05e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—POMC—alcohol dependence	1.27e-06	3.03e-05	CbGpPWpGaD
Fluvoxamine—CYP1A2—Metabolism—EP300—alcohol dependence	1.09e-06	2.61e-05	CbGpPWpGaD
Fluvoxamine—CYP3A4—Metabolism—EP300—alcohol dependence	8.44e-07	2.01e-05	CbGpPWpGaD
